US EditionCadila Pharmaceuticals marks three years of ThRabis, a three-dose rabies vaccine - Express Pharma
Summary by Express Pharma
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Cadila Pharmaceuticals marks three years of ThRabis, a three-dose rabies vaccine - Express Pharma
Cadila Pharmaceuticals has marked the third anniversary of ThRabis, reportedly the world’s first three-dose rabies vaccine. Developed by the company’s in-house research and development team, ThRabis was launched in April 2022 and is now in use across India and other countries. The vaccine has been introduced as an alternative to the traditional five-dose rabies regimen, with the aim of improving access and treatment adherence. ThRabis requires t…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
